6.80Open5.34Pre Close3 Volume37 Open Interest73.00Strike Price1.96KTurnover49.49%IV-0.91%PremiumDec 6, 2024Expiry Date6.83Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9559Delta0.0219Gamma11.49Leverage Ratio-0.0496Theta0.0080Rho10.98Eff Leverage0.0080Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet